|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8600 EUR | -3.91% |
|
-3.15% | -44.01% |
| 06-18 | AB Science Secures US Patent for Prostate Cancer Therapy | MT |
| 06-18 | AB Science Secures New U.S. Patent for Masitinib |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 78.57M | ||
| 50.8x | 5.78x | -0.73x | 4.75x | 19.31x | 26.83x | 2.94% | 281B | ||
| 22.45x | 1.89x | -16.81x | 3.1x | 11.03x | 18.09x | 1.75% | 66.27B | ||
| 16.49x | 1.42x | 0.82x | 2.08x | 7.14x | 8.53x | 2.71% | 8.24B | ||
| 10.18x | 10.77x | 0.06x | 5.26x | 8.1x | 8.9x | - | 8.13B | ||
| 21.9x | 6.1x | 1.32x | 6.55x | 17.91x | 18.7x | -.--% | 4.45B | ||
| 42.25x | 2.52x | -1.38x | 2.39x | 29.15x | 43.18x | 0.73% | 3.71B | ||
| 29.4x | - | 0.19x | 5.61x | 16.05x | 26.01x | - | 3.42B | ||
| 102.42x | - | -0.63x | - | - | - | -.--% | 2.58B | ||
| 12.61x | 0.84x | 0.89x | 1.13x | 28.49x | -77.63x | 4.06% | 1.01B | ||
| -7.43x | 12.42x | 0.46x | 205.42x | -6.61x | -5.18x | -.--% | 961M | ||
| 44.17x | 6.92x | -1.15x | 14.72x | 30.91x | 36.36x | - | 928M | ||
| 44.9x | - | -0.09x | - | - | - | - | 890M | ||
| Average | 32.51x | 5.41x | -1.42x | 25.10x | 16.15x | 10.38x | 1.52% | 29.38B | |
| Weighted average by Cap. | 43.73x | 5.08x | -3.44x | 4.95x | 17.39x | 24.24x | 2.64% |
- Stock Market
- Stocks
- AB Stock
- Sector AB Science
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















